BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29476952)

  • 1. Promising Outcome of Umbilical Cord Blood Transplantation in Patients with Multiple Comorbidities.
    Adachi Y; Ukai S; Sagou K; Fukushima N; Ozeki K; Kohno A
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1455-1462. PubMed ID: 29476952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy.
    Nakaya A; Mori T; Tanaka M; Tomita N; Nakaseko C; Yano S; Fujisawa S; Sakamaki H; Aotsuka N; Yokota A; Kanda Y; Sakura T; Nanya Y; Saitoh T; Kanamori H; Takahashi S; Okamoto S
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1553-9. PubMed ID: 25034961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
    Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants.
    Majhail NS; Brunstein CG; McAvoy S; DeFor TE; Al-Hazzouri A; Setubal D; Arora M; Le CT; Wagner JE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):985-992. PubMed ID: 18721761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation score allows a better stratification of high-risk patients undergoing reduced-toxicity allogeneic hematopoietic cell transplantation.
    Barba P; Martino R; Pérez-Simón JA; Fernández-Avilés F; Castillo N; Piñana JL; López-Anglada L; Rovira M; Bosch F; Carreras E; Corral LL; Sierra J; Valcárcel D
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):66-72. PubMed ID: 24141006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic implications of hematopoietic cell transplantation-specific comorbidity index on non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation].
    Wang CY; Ren HY; Qiu ZX; Wang Y; Cen XN; Wang LH; Wang MJ; Xu WL; Wang WS; Li Y; Dong YJ; Ou JP; Liang ZY; Liu W; Wang Q
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):659-63. PubMed ID: 23978015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of the Hematopoietic Cell Transplantation Comorbidity Index for Patients Undergoing Reduced-Intensity Conditioning Cord Blood Transplantation.
    Salit RB; Oliver DC; Delaney C; Sorror ML; Milano F
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):654-658. PubMed ID: 28189904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell transplantation for children with β-thalassemia major: multicenter experience in China.
    Li XY; Sun X; Chen J; Qin MQ; Luan Z; Zhu YP; Fang JP
    World J Pediatr; 2018 Feb; 14(1):92-99. PubMed ID: 29511925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic Cell Transplantation-Specific Comorbidity Index Predicts Morbidity and Mortality in Autologous Stem Cell Transplantation.
    Berro M; Arbelbide JA; Rivas MM; Basquiera AL; Ferini G; Vitriu A; Foncuberta C; Fernandez Escobar N; Requejo A; Milovic V; Yantorno S; Szelagoswki M; Martinez Rolon J; Bentolila G; Garcia JJ; Garcia P; Caeiro G; Castro M; Jaimovich G; Palmer S; Trucco JI; Bet LA; Shaw BE; Kusminsky GD
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1646-1650. PubMed ID: 28669923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia.
    Mo XD; Tang BL; Zhang XH; Zheng CC; Xu LP; Zhu XY; Wang Y; Liu HL; Yan CH; Chu XD; Chen H; Geng LQ; Liu KY; Sun ZM; Huang XJ
    Int J Cancer; 2016 Nov; 139(9):2106-15. PubMed ID: 27356906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) is an outcome predictor for partially matched related donor transplantation.
    Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
    Am J Hematol; 2013 Jun; 88(6):497-502. PubMed ID: 23536204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Single center comparative analysis of hematopoietic cell transplantation from alternated donor in patients with hematologic malignancies].
    Wang J; Zhou J; Zheng HF; Wang PF; Fu CC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):159-65. PubMed ID: 25687066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources.
    Elsawy M; Storer BE; Milano F; Sandmaier BM; Delaney C; Salit RB; Rashad AH; Woolfrey AE; Appelbaum FR; Storb R; Sorror ML
    Biol Blood Marrow Transplant; 2019 May; 25(5):1045-1052. PubMed ID: 30500442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploidentical Hematopoietic Stem Cell Transplantation Versus Umbilical Cord Blood Transplantation in Hematologic Malignancies: A Systematic Review and Meta-Analysis.
    Wu R; Ma L
    Cell Transplant; 2020; 29():963689720964771. PubMed ID: 33040595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in predicting outcomes for adolescents and young adults with hematologic malignancies undergoing allogeneic stem cell transplant.
    Wood W; Deal A; Whitley J; Sharf A; Serody J; Gabriel D; Shea T
    Pediatr Blood Cancer; 2011 Sep; 57(3):499-505. PubMed ID: 21384538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation.
    Veeraputhiran M; Yang L; Sundaram V; Arai S; Lowsky R; Miklos D; Meyer E; Muffly L; Negrin R; Rezvani A; Shizuru J; Weng WK; Johnston L
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1744-1748. PubMed ID: 28668491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation.
    Farina L; Bruno B; Patriarca F; Spina F; Sorasio R; Morelli M; Fanin R; Boccadoro M; Corradini P
    Leukemia; 2009 Jun; 23(6):1131-8. PubMed ID: 19194465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hematopoietic cell transplantation-specific comorbidity index fails to predict outcomes in high-risk AML patients undergoing allogeneic transplantation--investigation of potential limitations of the index.
    Birninger N; Bornhäuser M; Schaich M; Ehninger G; Schetelig J
    Biol Blood Marrow Transplant; 2011 Dec; 17(12):1822-32. PubMed ID: 21708108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study.
    Paviglianiti A; Tozatto Maio K; Rocha V; Gehlkopf E; Milpied N; Esquirol A; Chevallier P; Blaise D; Gac AC; Leblond V; Cahn JY; Abecasis M; Zuckerman T; Schouten H; Gurman G; Rubio MT; Beguin Y; Corral LL; Nagler A; Snowden JA; Koc Y; Mordini N; Bonifazi F; Volt F; Kenzey C; Robinson SP; Montoto S; Gluckman E; Ruggeri A
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2265-2270. PubMed ID: 30031070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an umbilical cord blood transplantation-specific nonrelapse mortality risk assessment score.
    Okada Y; Usui Y; Hayashi H; Nishikubo M; Toubai T; Uchida N; Tanaka M; Onizuka M; Takahashi S; Doki N; Uehara Y; Maruyama Y; Ishiwata K; Kawakita T; Sawa M; Eto T; Ishimaru F; Kato K; Fukuda T; Atsuta Y; Kanda J; Yakushijin K; Nakasone H
    Blood Adv; 2024 Mar; 8(6):1359-1368. PubMed ID: 38163321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.